- $444.05m
- $469.74m
- $187.34m
- 75
- 45
- 33
- 49
Annual cashflow statement for AxoGen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -23.8 | -27 | -28.9 | -21.7 | -9.96 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 10.9 | 15.1 | 17.6 | 14.8 | 16.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.212 | -6.28 | -9.56 | -4.39 | -10 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -9.63 | -13.4 | -16.1 | -5.72 | 4.54 |
| Capital Expenditures | -22.6 | -28.4 | -21.3 | -14.9 | -4.52 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 5.63 | 4.75 | 18.1 | 34.2 | -5.77 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -17 | -23.6 | -3.2 | 19.3 | -10.3 |
| Financing Cash Flow Items | -0.642 | 0 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 40.5 | 20.5 | 1.79 | 1.95 | 2.29 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 13.9 | -16.6 | -17.5 | 15.5 | -3.47 |